Literature DB >> 1520120

Diabeteslike preproliferative retinal changes in galactose-fed dogs.

Y Takahashi1, M Wyman, F Ferris, P F Kador.   

Abstract

Retinal vessel changes were experimentally investigated by a combination of color fundus photography, fluorescein angiography, and histologic studies in beagles that were fed a 30% galactose diet for up to 66 months. Previously, we have described the appearance of pericyte ghosts, microaneurysms, acellular capillaries, and intraretinal hemorrhages in dogs fed a galactose diet for up to 36 months. These disorders were similar to those observed in humans with background diabetic retinopathy. We report herein that dogs fed galactose for 48 to 60 months experience retinal changes associated with the chronic occlusion of capillary beds and subsequent ischemia of the retina. These changes included the appearance of broad areas of nonperfusion, soft exudates (cytoid bodies), intraretinal microvascular abnormalities, occluded arterioles, preretinal and intravitreal hemorrhages, and apparent new vessel growth around the optic disc. The present study clearly demonstrates that the galactose-fed dog is an animal model in which advanced retinal changes develop, and these changes are similar to those associated with preproliferative human diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520120     DOI: 10.1001/archopht.1992.01080210113037

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  10 in total

1.  A rare galactosemia complication: vitreous hemorrhage.

Authors:  Sahin Takci; Sibel Kadayifcilar; Turgay Coskun; Sule Yigit; Burcu Hismi
Journal:  JIMD Rep       Date:  2011-12-11

2.  Experimental nonenzymatic glycosylation of vitreous collagens occurs by two pathways.

Authors:  J S Pulido
Journal:  Trans Am Ophthalmol Soc       Date:  1996

3.  Histological evaluation of the canine retinal vasculature following chronic systemic administration of basic fibroblast growth factor.

Authors:  J L Jacot; N M Laver; J P Glover; D F Lazarous; E F Unger; W G Robison
Journal:  J Anat       Date:  1996-04       Impact factor: 2.610

4.  Correlation between erythrocyte aldose reductase level and human diabetic retinopathy.

Authors:  N Oishi; E Kubo; Y Takamura; K Maekawa; T Tanimoto; Y Akagi
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

5.  Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs.

Authors:  T A Gardiner; A W Stitt; H R Anderson; D B Archer
Journal:  Br J Ophthalmol       Date:  1994-01       Impact factor: 4.638

6.  The natural history of the first clinically visible features of diabetic retinopathy.

Authors:  S S Feman
Journal:  Trans Am Ophthalmol Soc       Date:  1994

7.  Retinopathy in diabetic hypertensive monkeys: a pathologic study.

Authors:  E R Büchi; A Kurosawa; M O Tso
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-06       Impact factor: 3.117

Review 8.  Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals.

Authors:  Remya Robinson; Veluchamy A Barathi; Shyam S Chaurasia; Tien Y Wong; Timothy S Kern
Journal:  Dis Model Mech       Date:  2012-07       Impact factor: 5.758

Review 9.  Animal models of diabetic retinopathy: doors to investigate pathogenesis and potential therapeutics.

Authors:  Dong Hyun Jo; Chang Sik Cho; Jin Hyoung Kim; Hyoung Oh Jun; Jeong Hun Kim
Journal:  J Biomed Sci       Date:  2013-06-20       Impact factor: 8.410

10.  Novel diabetic mouse models as tools for investigating diabetic retinopathy.

Authors:  Peter F Kador; Peng Zhang; Jun Makita; Zifeng Zhang; Changmei Guo; James Randazzo; Hiroyoshi Kawada; Neena Haider; Karen Blessing
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.